The average one-year price target for IQM Quantum Computers Oyj - Depositary Receipt (NASDAQGS:IQMX) (DB:561) has been revised to $16.58 / share. This is an increase of 30.00% from the prior estimate of $12.75 dated September 11, 2026. These figures represent aggregate analyst ta
The average one-year price target for Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) has been revised to $0.13 / share, up 19.98% from the prior estimate of $0.11 dated September 13, 2026. These figures represent aggregate analyst targets compiled by Fint
(RTTNews) - Nanobiotix S.A. (NBTX), a late-stage clinical biotechnology company developing physics-based nano-therapeutics for cancer and other major diseases, announced the appointment of Arnd Christ as Chief Financial Officer (CFO) and a member of its executive board.
(RTTNews) - Addex Therapeutics Ltd. (ADXN), a clinical-stage biopharmaceutical company, on Friday announced the appointment of Jean-Phillippe Rocher as the Head of Pharmaceutical Development, and a member of the Executive Management.
The average one-year price target for TruGolf Holdings (NASDAQCM:TRUG) has been revised to $61.20 / share. This is an increase of 900.00% from the prior estimate of $6.12 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not con
(RTTNews) - Daiichi Sankyo (4568.TS) and AstraZeneca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination with ivonescimab across multiple solid tumor types, expanding efforts
(RTTNews) - Boeing's (BA) engineers and technical employees have approved a new four-year contract, their union said, removing the threat of another strike at the aviation giant.
(RTTNews) - The following biotech stocks reached a 52-week high on October 1, 2026, driven by key catalysts such as promising results from clinical trials or revised financial guidance.
Corn futures were fighting to stay above $5 for much of the session despite hitting a low of $4.95 in the December contract. Bulls battled back to close with contracts steady to 1 ½ cents higher. The CmdtyView national average Cash Corn price was up 3 1/4 cents at $4.61...
The average one-year price target for Charles River Laboratories International (NYSE:CRL) (BMV:CRL) has been revised to $307.39 / share, up 11.46% from the prior estimate of $275.80 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and
The average one-year price target for Universal Technical Institute (NYSE:UTI) (DB:UTI) has been revised to $37.59 / share. This is a decrease of 11.95% from the prior estimate of $42.69 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Finte
(RTTNews) - S&P Dow Jones Indices have announced the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600. Vylor Inc. (VYLR) was added to the S&P 500 on October 1, when S&P 500 constituent Corteva Inc. (CTVA) spun off Vylor.
(RTTNews) - Sweco AB (SWEC-B.ST, SWEC-A.ST), an architecture and engineering consultancy, on Friday announced that President and CEO Åsa Bergman has resigned from her position and will leave the company.
(RTTNews) - Daiichi Sankyo (4568.TS) and AstraZenca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination with ivonescimab across multiple solid tumors, including lung and brea
Checked
12 minutes 7 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article